ROC curve analysis in the merged data was used to assess the sensitivity and specificity of CDCA2 as a diagnostic biomarker for HCC with an AUC value of 0.911 (0.888–0.934) (Figure 2D). Here, CDCA2 is linked to hepatocellular carcinoma.